From the Journals
From the Journals
Whole brain radiotherapy not beneficial for NSCLC metastasis
Whole brain radiotherapy provided no clinically significant benefit for most patients with metastatic non–small-cell lung cancer.
From the Journals
Pneumonitis with nivolumab treatment shows common radiographic patterns
Among 20 cancer patients treated with this PD-1 inhibitor who developed pneumonitis, cryptogenic organizing pneumonia was seen in 13.
From the Journals
IASLC lung cancer staging project proposes changes for new TNM classification
Key clinical point: New lung cancer classification to become effective January 2017. Major finding: Size will now be a descriptor in all T...
From the Journals
Wanted: Better evidence on fast-track lung resection
Key clinical point: Well-designed clinical trials are needed to determine the effectiveness of fast-track recovery pathways in lung resection.
From the Journals
NSQIP calculator shown inadequate to stratify risk in stage I non–small cell lung cancer.
Key clinical point: The current NSQIP Surgical Risk Calculator does not adequately estimate risk among patients with clinical stage I non–small...
From the Journals
Alectinib shows promise in crizotinib-refractory ALK-rearranged NSCLC
Key clinical point: Alectinib, an oral, small molecule inhibitor of ALK, showed promising clinical activity in crizotinib-refractory patients with...
From the Journals
‘Minimalist’ TAVR has short learning curve
Key clinical point: A minimalist approach to transcatheter aortic valve replacement (MA-TAVR) is feasible with acceptable outcomes. Major finding...
From the Journals
3-D–printed devices mitigate pediatric tracheobronchomalacia
Three infants are thriving after artificial 3-D–printed airways were used. Immediate and continued life-sustaining improvement was seen in three...
From the Journals
Surgeon volume may affect choice of surgery type for NSCLC
Key clinical point: Surgeon volume is a predictor of procedure selection for lung cancer surgery and has implications on outcomes. Major finding:...
From the Journals
Consolidation chemotherapy after concurrent chemoradiation failed to improve outcomes in NSCLC
Key clinical point: Docetaxel and cisplatin consolidation chemotherapy (CC) after concurrent chemoradiation failed to prolong progression-free...